Vaxinano is working with pharmaceutical companies to develop or improve vaccines in both human and animal health.
Vaxinano is also developing the proof-of-concept of new vaccines for further development with pharmaceutical leaders.
A large range of infectious diseases are under investigation, notably an anti-parasitic vaccine for chronic and congenital toxoplasmosis for which there is currently neither a treatment nor a vaccine for humans. We are also studying the improvement of existing tuberculosis vaccines.
